U.S. markets open in 6 hours 29 minutes
  • S&P Futures

    4,205.25
    -17.75 (-0.42%)
     
  • Dow Futures

    33,864.00
    -153.00 (-0.45%)
     
  • Nasdaq Futures

    13,901.50
    -79.75 (-0.57%)
     
  • Russell 2000 Futures

    2,297.30
    -12.80 (-0.55%)
     
  • Crude Oil

    71.74
    -0.41 (-0.57%)
     
  • Gold

    1,815.20
    -46.20 (-2.48%)
     
  • Silver

    27.05
    -0.76 (-2.74%)
     
  • EUR/USD

    1.1989
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.5690
    0.0000 (0.00%)
     
  • Vix

    18.15
    +1.13 (+6.64%)
     
  • GBP/USD

    1.3997
    +0.0010 (+0.07%)
     
  • USD/JPY

    110.6350
    +0.0220 (+0.02%)
     
  • BTC-USD

    39,239.87
    -1,165.56 (-2.88%)
     
  • CMC Crypto 200

    975.11
    -17.36 (-1.75%)
     
  • FTSE 100

    7,184.95
    0.00 (0.00%)
     
  • Nikkei 225

    29,018.33
    -272.68 (-0.93%)
     

Astronics Corporation Reports 2021 First Quarter Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·19 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Sales for the quarter were $105.9 million, slightly better than guidance

  • Net loss was $11.9 million

  • Adjusted EBITDA* loss was $0.5 million

  • Bookings for the quarter continued sequential improvement to $120.0 million

  • Backlog at the end of the quarter was $297.5 million

*Adjusted EBITDA is a Non-GAAP Performance Measure. Please see the attached table for a reconciliation of adjusted EBITDA to GAAP net income .

Astronics Corporation (Nasdaq: ATRO) ("Astronics" or the "Company"), a leading supplier of advanced technologies and products to the global aerospace, defense and other mission critical industries, today reported financial results for the three months ended April 3, 2021.

Peter J. Gundermann, the Company’s President and CEO, commented, "As we expected, our first quarter was a slow start to the year. However, our Aerospace bookings continue to recover, increasing 36% sequentially from the fourth quarter, resulting in our first positive Aerospace book-to-bill ratio of 1.23 since the pandemic began over a year ago. We are encouraged that the industry seems poised for recovery as the pandemic comes under control."

First Quarter Summary and Review of Major Markets

First quarter revenue was $105.9 million, down 32.8% from the comparator period of 2020. The Company incurred a net loss of $11.9 million and an adjusted EBITDA loss of $0.5 million, or 0.5% of sales.

The Company evaluates three revenue streams to monitor demand and analyze the impact of the pandemic to its business. These are (1) the commercial aircraft market, which includes OEM line fit and airline aftermarket business, (2) defense and other government markets, and (3) general aviation.

  • Commercial aerospace continues to be heavily impacted by the pandemic and was
    $38.2 million, or 36% of total revenue in the quarter, compared with $102.8 million, or 65% of total revenue in the first quarter of 2020. Narrow body aircraft build rates are expected to improve through 2021 from current levels as production of the 737 MAX picks up. The aftermarket is expected to strengthen over the course of the year as aircraft utilization and load factors increase.

  • Defense and government markets, including our military aircraft sales and test segment sales*, have remained strong through the pandemic. Sales to these markets were
    $45.4 million, or 43% of first quarter revenue in 2021, up from $33.0 million, or 21% in the comparator period of 2020.

  • General aviation sales were $14.0 million, representing about 13% of first quarter revenue in 2021. This compares with $15.0 million, or 10% of revenue in the comparator period. Most of general aviation revenue is line fit production driven by the manufacture of new aircraft, although there is some amount of aftermarket business as well. Demand for private aircraft has recovered quickly and is expected to result in higher aircraft production rates in the near future.

  • Other revenue was about 8% of total revenue in the first quarter of 2021.

* Test segment sales discussed in Defense and Government markets for 2020 excludes sales to the semiconductor industry.

Liquidity and Financing

In May 2020, the Company executed an amendment to its credit agreement (the "amended facility") which reduced the revolving credit line from $500 million to $375 million. The amended facility suspended the application of the maximum net leverage ratio covenant up through and including the second quarter of 2021. The maximum net leverage ratio on a trailing twelve-month basis will resume at 6.00 to 1 for the third quarter of 2021, 5.50 to 1 for the fourth quarter of 2021, 4.50 to 1 for the first quarter of 2022, and return to 3.75 to 1 in the second quarter of 2022 and thereafter. As of April 3, 2021, the Company had $173.0 million drawn on the facility, with net debt of $142.3 million.

In addition, through the second quarter of 2021, other financial covenants require the Company to maintain a minimum interest coverage ratio of 1.75x on a quarterly basis, except for the first quarter of 2021, which was set at 1.50x. Also, through the third quarter of 2021, the Company must maintain minimum liquidity, defined as unrestricted cash plus the unused revolving credit commitments, of $180 million at all times. The amended facility also temporarily restricts certain activities, including acquisitions and share repurchases, and requires mandatory prepayments during the suspension period when the Company’s cash balance exceeds $100 million.

Cash used in operations totaled $6.9 million in the first quarter. The Company was compliant with its debt covenants as of the end of the first quarter and expects to remain compliant.

In February 2021, the Company was notified by the acquirer of its semiconductor business, which was sold in February 2019, that $10.7 million is payable to the Company for earnouts related to 2020. In April 2021, the acquirer provided a revised calculation, indicating, rather, that

$7.1 million is payable to the Company for the 2020 earnout. The Company is currently reviewing the calculations and underlying data and expects to record the additional gain on the sale when that review is complete and the issue resolved.

First Quarter Results

Three Months Ended

($ in thousands)

April 3, 2021

March 28, 2020

% Change

Sales

$

105,857

$

157,584

(32.8)

%

Loss from Operations

$

(9,512)

$

(67,556)

(85.9)

%

Operating Margin %

(9.0)

%

(42.9)

%

Net Loss

$

(11,909)

$

(66,963)

(82.2)

%

Net Loss %

(11.3)

%

(42.5)

%

*Adjusted EBITDA

$

(496)

$

16,763

(103.0)

%

*Adjusted EBITDA Margin %

(0.5)

%

10.6

%

*Adjusted EBITDA is a Non-GAAP Performance Measure. Please see the attached table for a reconciliation of adjusted EBITDA to GAAP net income.

First Quarter 2021 Results (compared with the prior-year period, unless noted otherwise)

Consolidated sales were down $51.7 million. Aerospace sales were down $59.7 million from the 2020 first quarter, which had been largely unaffected by the COVID pandemic. Test System sales increased $7.9 million.

Consolidated operating loss was $9.5 million, compared with operating loss of $67.6 million in the prior-year period. The loss in the first quarter of 2021 was due to low volume related to the continued impacts of the COVID-19 pandemic on the global aerospace industry. The prior-year period reflected non-cash goodwill and other asset impairment charges of $74.4 million in the aerospace segment due to revised expectations regarding future operating results as the COVID-19 pandemic took hold.

Consolidated net loss was $11.9 million, or $0.39 per diluted share, compared with net loss of $67.0 million, or $2.17 per diluted share, in the prior year. The after-tax impact of the prior year impairment was $68.8 million, or $2.23 per diluted share.

Consolidated adjusted EBITDA loss was $0.5 million, or 0.5% of consolidated sales, compared with adjusted EBITDA of $16.8 million, or 10.6% of consolidated sales, in the prior-year period.

Bookings were $120.0 million resulting in a book-to-bill ratio of 1.13:1. Backlog at the end of the quarter was $297.5 million. Approximately $217.2 million, or 73%, of backlog is expected to ship in the remainder of 2021.

Aerospace Segment Review (refer to sales by market and segment data in accompanying tables)

Aerospace First Quarter 2021 Results (compared with the prior-year period, unless noted otherwise)

Aerospace segment sales decreased $59.7 million, or 42.3%, to $81.4 million. Sales continued to be negatively affected by low commercial aircraft build rates and a weak commercial aircraft aftermarket as airlines have reduced spending and grounded aircraft due to the global COVID-19 pandemic.

Aerospace segment operating loss was $5.6 million compared with operating loss of $63.1 million for the same period last year. Leverage lost on reduced sales significantly impacted operating results. Aerospace operating profit in the prior-year period was impacted by goodwill and other asset impairment charges of $74.4 million, as previously discussed.

Aerospace bookings in the first quarter of 2021 improved sequentially by 36%, to $100.5 million, for a book-to-bill ratio for the quarter of 1.23:1. Backlog was $210.2 million at the end of the first quarter of 2021.

Test Systems Segment Review (refer to sales by market and segment data in accompanying tables)

Test Systems First Quarter 2021 Results (compared with the prior-year period, unless noted otherwise)

Test Systems segment sales were $24.4 million, up $7.9 million compared with the prior-year period.

Test Systems operating profit was $1.2 million, or 4.9% of sales, compared with $0.7 million, or 4.4% of sales, in the first quarter of 2020. Operating profit in the first quarter of 2021 was negatively affected by $0.9 million in legal fees related to infringement claims. Operating results in 2020 benefited from $1.6 million in semiconductor warranty revenue.

Bookings for the Test Systems segment in the quarter were $19.5 million, for a book-to-bill ratio of 0.80:1 for the quarter. Backlog was $87.4 million at the end of the first quarter of 2021.

2021 Outlook

Mr. Gundermann commented, "We are pleased with the continued strong demand for our Test business, which had core sales up 64% over last year. We also are encouraged by the consistent sequential ramping of Aerospace bookings since the second quarter of last year. We are optimistic that demand will strengthen as 2021 progresses, but it is too early to forecast results confidently. However, we expect our revenue in the second quarter to be about $115 million. Our goals remain to generate cash and reduce debt. Evidence suggests that our largest market, which is dependent upon the health of the commercial airline industry, will recover when and where the pandemic comes under control. While we are making strides in the U.S., we look forward to progress in this regard worldwide through the remainder of this year."

Our expectation for capital expenditures for 2021 remain unchanged at approximately $10 million to $11 million.

First Quarter 2021 Webcast and Conference Call

The Company will host a teleconference today at 11:00 a.m. ET. During the teleconference, management will review the financial and operating results for the period and discuss Astronics’ corporate strategy and outlook. A question-and-answer session will follow.

The Astronics conference call can be accessed by calling 201.493.6784. The listen-only audio webcast can be monitored at www.astronics.com. To listen to the archived call, dial 412.317.6671 and enter replay pin number 13718343. The telephonic replay will be available from 2:00 p.m. on the day of the call through Thursday, May 13, 2021. A transcript of the call will also be posted to the Company’s Web site once available.

About Astronics Corporation

Astronics Corporation (Nasdaq: ATRO) serves the world’s aerospace, defense, and other mission critical industries with proven, innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors, and test technologies to solve complex challenges. For over 50 years, Astronics has delivered creative, customer-focused solutions with exceptional responsiveness. Today, global airframe manufacturers, airlines, military branches, completion centers, and Fortune 500 companies rely on the collaborative spirit and innovation of Astronics. The Company’s strategy is to increase its value by developing technologies and capabilities that provide innovative solutions to its targeted markets.

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Securities Exchange Act of 1934. One can identify these forward-looking statements by the use of the words "expect," "anticipate," "plan," "may," "will," "estimate" or other similar expressions and include all statements with regard to the impact of COVID-19 on the Company and its future, reaching any revenue or Adjusted EBITDA margin expectations, being cash positive in 2021, the recovery of the commercial aerospace market, the opportunities to leverage capabilities in other markets and the outcome of demand streams or expectations of demand by customers and markets. Because such statements apply to future events, they are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the statements. Important factors that could cause actual results to differ materially from what may be stated here include the impact of the global outbreak of COVID-19 and governmental and other actions taken in response, trend in growth with passenger power and connectivity on airplanes, the state of the aerospace and defense industries, the market acceptance of newly developed products, internal production capabilities, the timing of orders received, the status of customer certification processes and delivery schedules, the demand for and market acceptance of new or existing aircraft which contain the Company’s products, the need for new and advanced test and simulation equipment, customer preferences and relationships, and other factors which are described in filings by Astronics with the Securities and Exchange Commission. The Company assumes no obligation to update forward-looking information in this news release whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise.

FINANCIAL TABLES FOLLOW

ASTRONICS CORPORATION

CONSOLIDATED STATEMENT OF OPERATIONS DATA

(Unaudited, $ in thousands except per share data)

Three Months Ended

4/3/2021

3/28/2020

Sales

$

105,857

$

157,584

Cost of products sold

91,584

121,865

Gross profit

14,273

35,719

Gross margin

13.5

%

22.7

%

Selling, general and administrative

23,785

28,867

SG&A % of sales

22.5

%

18.3

%

Impairment loss1

74,408

Loss from operations

(9,512)

(67,556)

Operating margin

(9.0)

%

(42.9)

%

Other expense, net of other income

534

388

Interest expense, net

1,758

1,333

Loss before tax

(11,804)

(69,277)

Income tax expense (benefit)

105

(2,314)

Net loss

$

(11,909)

$

(66,963)

Net loss % of sales

(11.3)

%

(42.5)

%

*Basic loss per share:

$

(0.39)

$

(2.17)

*Diluted loss per share:

$

(0.39)

$

(2.17)

*Weighted average diluted shares outstanding (in thousands)

30,903

30,814

Capital expenditures

$

1,905

$

2,793

Depreciation and amortization

$

7,453

$

7,971

1 Impairment loss primarily represents the goodwill impairment charges incurred in the Aerospace segment. Full impairment charges totaling $73.7 million were recorded in Q1 2020 for goodwill associated to the CSC, PGA and CCC reporting units and a partial goodwill impairment was recorded at the PECO reporting unit.

ASTRONICS CORPORATION

SEGMENT DATA

(Unaudited, $ in thousands)

Three Months Ended

4/3/2021

3/28/2020

Sales

Aerospace

$

81,430

$

141,137

Less inter-segment

(14)

(67)

Total Aerospace

81,416

141,070

Test Systems

24,745

16,553

Less inter-segment

(304)

(39)

Total Test Systems

24,441

16,514

Total consolidated sales

105,857

157,584

Segment operating loss and margins

Aerospace

(5,563)

(63,145)

(6.8)

%

(44.8)

%

Test Systems

1,189

722

4.9

%

4.4

%

Total segment operating loss

(4,374)

(62,423)

Interest expense

1,758

1,333

Corporate expenses and other

5,672

5,521

Loss before taxes

$

(11,804)

$

(69,277)

Reconciliation to Non-GAAP Performance Measures

In addition to reporting net income, a U.S. generally accepted accounting principle ("GAAP") measure, we present Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, non-cash equity-based compensation expense, goodwill, intangible and long-lived asset impairment charges, equity investment income or loss, legal reserves, settlements and recoveries, restructuring charges and gains or losses associated with the sale of businesses), which is a non-GAAP measure. The Company’s management believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the performance of its core operations from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, equity-based compensation expense, goodwill, intangible and long-lived asset impairment charges, equity investment income or loss, legal reserves, settlements and recoveries, restructuring charges and gains or losses associated with the sale of businesses, which is not commensurate with the core activities of the reporting period in which it is included. As such, the Company uses Adjusted EBITDA as a measure of performance when evaluating its business and as a basis for planning and forecasting. Adjusted EBITDA is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. Adjusted EBITDA, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.

ASTRONICS CORPORATION

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA

(Unaudited, $ in thousands)

Consolidated

Three Months Ended

4/3/2021

3/28/2020

Net loss

$

(11,909)

$

(66,963)

Add back (deduct):

Interest expense

1,758

1,333

Income tax expense (benefit)

105

(2,314)

Depreciation and amortization expense

7,453

7,971

Equity-based compensation expense

2,097

1,703

Goodwill and other asset impairments

74,408

Restructuring-related charges including severance

518

Equity investment loss

107

Adjusted EBITDA

$

(496)

$

16,763

Sales

$

105,857

$

157,584

Adjusted EBITDA margin

(0.5)

%

10.6

%

ASTRONICS CORPORATION

CONSOLIDATED BALANCE SHEET DATA

($ in thousands)

(unaudited)

4/3/2021

12/31/2020

ASSETS

Cash and cash equivalents

$

30,729

$

40,412

Accounts receivable and uncompleted contracts

98,701

93,056

Inventories

155,254

157,059

Other current assets

25,552

26,420

Property, plant and equipment, net

104,931

106,678

Other long-term assets

26,563

27,952

Intangible assets, net

105,930

109,886

Goodwill

58,297

58,282

Total assets

$

605,957

$

619,745

LIABILITIES AND SHAREHOLDERS' EQUITY

Accounts payable and accrued expenses

$

67,795

$

69,165

Customer advances and deferred revenue

27,407

24,571

Long-term debt

173,000

173,000

Other liabilities

77,451

82,638

Shareholders' equity

260,304

270,371

Total liabilities and shareholders' equity

$

605,957

$

619,745

ASTRONICS CORPORATION

CONSOLIDATED CASH FLOWS DATA

Three Months Ended

(Unaudited, $ in thousands)

4/3/2021

3/28/2020

Cash flows from operating activities:

Net loss

$

(11,909)

$

(66,963)

Adjustments to reconcile net loss to cash from operating activities:

Depreciation and amortization

7,453

7,971

Provisions for non-cash losses on inventory and receivables

1,269

872

Equity-based compensation expense

2,097

1,703

Deferred tax (benefit) expense

(51)

2,050

Operating lease non-cash expense

1,185

1,210

Impairment loss

74,408

Other

1,315

968

Cash flows from changes in operating assets and liabilities:

Accounts receivable

(6,010)

13,644

Inventories

430

(7,224)

Accounts payable

(4,171)

6,295

Accrued expenses

(685)

(5,730)

Other current assets and liabilities

961

(557)

Customer advanced payments and deferred revenue

2,915

(490)

Income taxes

(246)

(3,591)

Operating lease liabilities

(1,307)

(1,217)

Supplemental retirement plan and other liabilities

(109)

(99)

Cash flows from operating activities

(6,863)

23,250

Cash flows from investing activities:

Capital expenditures

(1,905)

(2,793)

Cash flows from investing activities

(1,905)

(2,793)

Cash flows from financing activities:

Proceeds from long-term debt

150,000

Principal payments on long-term debt

(5,000)

Purchase of outstanding shares for treasury

(7,732)

Stock option activity

(52)

33

Finance lease principal payments

(501)

(461)

Cash flows from financing activities

(553)

136,840

Effect of exchange rates on cash

(362)

(839)

(Decrease) Increase in cash and cash equivalents

(9,683)

156,458

Cash and cash equivalents at beginning of period

40,412

31,906

Cash and cash equivalents at end of period

$

30,729

$

188,364

ASTRONICS CORPORATION

SALES BY MARKET

(Unaudited, $ in thousands)

Three Months Ended

4/3/2021

3/28/2020

% Change

% of Sales

Aerospace Segment

Commercial Transport

$

38,208

$

102,775

(62.8)

%

36.1

%

Military

20,982

18,113

15.8

%

19.8

%

Business Jet

14,028

15,006

(6.5)

%

13.3

%

Other

8,198

5,176

58.4

%

7.7

%

Aerospace Total

81,416

141,070

(42.3)

%

76.9

%

Test Systems Segment excluding Semiconductor

24,441

14,880

64.3

%

23.1

%

Total sales excluding Semiconductor

105,857

155,950

(32.1)

%

100.0

%

Test-Semiconductor

1,634

(100.0)

%

%

Total Sales

$

105,857

$

157,584

(32.8)

%

SALES BY PRODUCT LINE

(Unaudited, $ in thousands)

Three Months Ended

4/3/2021

3/28/2020

% Change

% of Sales

Aerospace Segment

Electrical Power & Motion

$

29,344

$

69,456

(57.8)

%

27.8

%

Lighting & Safety

27,100

37,922

(28.5)

%

25.6

%

Avionics

14,843

22,143

(33.0)

%

14.0

%

Systems Certification

878

3,331

(73.6)

%

0.8

%

Structures

1,053

3,042

(65.4)

%

1.0

%

Other

8,198

5,176

58.4

%

7.7

%

Aerospace Total

81,416

141,070

(42.3)

%

76.9

%

Test Systems Segment excluding Semiconductor

24,441

14,880

64.3

%

23.1

%

Total sales excluding Semiconductor

105,857

155,950

(32.1)

%

100.0

%

Test-Semiconductor

1,634

(100.0)

%

%

Total Sales

$

105,857

$

157,584

(32.8)

%

ASTRONICS CORPORATION

ORDER AND BACKLOG TREND

(Unaudited, $ in thousands)

Q2 2020

Q3 2020

Q4 2020

Q1 2021

Trailing Twelve Months

6/27/2020

9/26/2020

12/31/2020

4/3/2021

4/3/2021

Sales

Aerospace

$

102,573

$

82,548

$

91,797

$

81,416

$

358,334

Test Systems (excluding Semi)

19,933

23,373

22,930

24,441

90,677

Sales (excluding Semi)

122,506

105,921

114,727

105,857

449,011

Test-Semiconductor

1,188

585

76

1,849

Total Sales

$

123,694

$

106,506

$

114,803

$

105,857

$

450,860

Bookings

Aerospace

$

43,264

$

64,956

$

74,106

$

100,488

$

282,814

Test Systems (excluding Semi)

18,230

16,602

41,877

19,497

96,206

Bookings (excluding Semi)

61,494

81,558

115,983

119,985

379,020

Test-Semiconductor

Total Bookings

$

61,494

$

81,558

$

115,983

$

119,985

$

379,020

Backlog

Aerospace

$

226,364

$

208,772

$

191,081

$

210,153

Test Systems (excluding Semi)

80,161

73,390

92,337

87,393

Backlog (excluding Semi)

306,525

282,162

283,418

297,546

Test-Semiconductor

661

76

Total Backlog

$

307,186

$

282,238

$

283,418

$

297,546

N/A

Book:Bill Ratio 1

Aerospace

0.42

0.79

0.81

1.23

0.79

Test Systems excl. Semi

0.91

0.71

1.83

0.80

1.06

Total Book:Bill excl. Semi

0.50

0.77

1.01

1.13

0.84

1 Calculations of Test Systems and Total Book:Bill excludes the total semiconductor business, which included residual warranty backlog following the divestiture.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210506005218/en/

Contacts

Company:
David C. Burney, Chief Financial Officer
Phone: (716) 805-1599, ext. 159
Email: david.burney@astronics.com

Investor Relations:
Deborah K. Pawlowski, Kei Advisors LLC
Phone: (716) 843-3908
Email: dpawlowski@keiadvisors.com